608 related articles for article (PubMed ID: 30527950)
21. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
[TBL] [Abstract][Full Text] [Related]
22. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
23. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
[TBL] [Abstract][Full Text] [Related]
24. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.
Winship AL; Willson C; Hansen KR; Hutt KJ; Hickey M
BMJ Open; 2019 Nov; 9(11):e033810. PubMed ID: 31772111
[TBL] [Abstract][Full Text] [Related]
25. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
[TBL] [Abstract][Full Text] [Related]
26. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
Gayete-Lafuente S; Turan V; Oktay KH
J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
[TBL] [Abstract][Full Text] [Related]
27. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
[TBL] [Abstract][Full Text] [Related]
28. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
[TBL] [Abstract][Full Text] [Related]
29. BRCA mutations and reproduction.
Daum H; Peretz T; Laufer N
Fertil Steril; 2018 Jan; 109(1):33-38. PubMed ID: 29307397
[TBL] [Abstract][Full Text] [Related]
30. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
31. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
32. The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status.
C E DK; C VTT; J C EM; G W M LE; Irene H; Mariette G; J T VGR; Willem V; D LK; J M BF; M E BA
Reprod Sci; 2023 Jan; 30(1):270-282. PubMed ID: 35705781
[TBL] [Abstract][Full Text] [Related]
33. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
34. Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies.
Lekovich J; Lobel ALS; Stewart JD; Pereira N; Kligman I; Rosenwaks Z
J Assist Reprod Genet; 2016 May; 33(5):657-662. PubMed ID: 26943918
[TBL] [Abstract][Full Text] [Related]
35. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
Turan V; Oktay K
Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.
Pereira N; Hubschmann AG; Lekovich JP; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Aug; 108(2):357-360. PubMed ID: 28629583
[TBL] [Abstract][Full Text] [Related]
37. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
Merlino L; Chiné A; Galli C; Piccioni MG
Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
[TBL] [Abstract][Full Text] [Related]
38. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
[TBL] [Abstract][Full Text] [Related]
39. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
40. Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.
Denis-Laroque L; Drouet Y; Plotton I; Chopin N; Bonadona V; Lornage J; Salle B; Lasset C; Rousset-Jablonski C
Breast; 2021 Oct; 59():239-247. PubMed ID: 34304065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
